Skip to Content
Merck
CN
  • Inhibitory effects of hybrid liposomes on the growth of synoviocyte causing rheumatoid arthritis.

Inhibitory effects of hybrid liposomes on the growth of synoviocyte causing rheumatoid arthritis.

Bioorganic & medicinal chemistry letters (2010-12-03)
Hideaki Ichihara, Motoki Hino, Taku Makizono, Masayo Umebayashi, Yoko Matsumoto, Ryuichi Ueoka
ABSTRACT

Inhibitory effects of HL-n composed of 95 mol% L-α-dimyristoylphosphatidylcholin (DMPC) and 5 mol% polyoxyethylenedodecylether (C(12)(EO)(n), n = 21, 23, or 25) on the growth of human rheumatoid arthritis (RA) fibroblast-like synoviocytes (HFLS-RA) in vitro were examined. Remarkably high inhibitory effects of HL-n on the growth of HFLS-RA cells were obtained. The induction of apoptosis by HL-n was revealed on the basis of TUNEL method. Furthermore, the therapeutic effects of HL-23 using mouse models of arthritis were investigated. Therapeutic effects without joint swelling were obtained in mouse models of RA treated with HL.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Brij® L23 solution, 30 % (w/v) in H2O
Sigma-Aldrich
Thesit®
Sigma-Aldrich
Decaethylene glycol mono­dodecyl ether, nonionic surfactant
Sigma-Aldrich
ECO Brij® L23
Sigma-Aldrich
Brij® L23, main component: tricosaethylene glycol dodecyl ether
Sigma-Aldrich
Brij® L23, suitable for Stein-Moore chromatography